The cardiology community is paying close attention to developments related to transcatheter mitral valve replacement (TMVR) for mitral regurgitation. Although TMVR is in its infancy, one big question on everyone’s minds is whether its impact will be on the same scale as transcatheter aortic valve replacement (TAVR).
Cardiologists are receiving more exposure to different imaging modalities during their fellowships, but their job prospects and training vary widely. A more comprehensive and multimodality training approach could lead to better results.
Ask cardiologists to name the big advances of the past decade, and many point to transcatheter aortic valve replacement (TAVR) and other breakthroughs that are allowing cardiologists to treat structural heart disease with minimally invasive procedures. Looking ahead, some believe that even bigger, broader changes are coming.